Welcome to the Institutional Repository CONACYT


Bienvenido al Repositorio Nacional de México

Este es el medio de Acceso Abierto que el CONACyT ha habilitado para la consulta y el depósito de los recursos de información científica, tecnológica y de innovación (RIACTIs). El Repositorio Nacional busca poner a disposición del público en general los recursos de información derivados de proyectos de investigación científica, tecnológica y la innovación para facilitar su consulta, uso y reúso.

Browsing by Title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Showing results 6421 to 6440 of 7832


Issue DateTitlePublication Type/ Resource TypeAuthor(s)Submit Date
2019S gene and 5a accessory gene are responsible for the attenuation of virulent infectious bronchitis coronavirusPreimpresoZhao, Y; Cheng, J; Yan, S; Jia, W; Zhang, K; Zhang, G-
2020SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19).ArtículoH Li.; X Xiang.; H Ren.; L Xu.; L Zhao.; X Chen.; H Long.; Q Wang.; Q Wu.-
2020Safe patient transport for COVID-19PreimpresoLiew, M; Siow, W; Yau, Y; See, K-
2020Safeguarding the Maintenance Hemodialysis Patient Population during the Coronavirus Disease 19 Pandemic.ArtículoMeijers Bjorn.; Messa Piergiorgio.; Ronco Claudio.-
2020Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patientsPreimpresoChen, R; Zhang, Y; Huang, L; Cheng, B; Xia, Z; Meng, Q-
2020Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patientsArtículoChen Rong.; Zhang Yuan.; Huang Lei.; Cheng Bi-heng.; Xia Zhong-yuan.; Meng Qing-tao.-
9-Feb-2022Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in MexicoPreimpresoSAMUEL PONCE DE LEON ROSALES; MARTHA TORRES ROJAS; LUIS ENRIQUE SOTO RAMIREZ; JUAN JOSE CALVA MERCADO; patricio santillan_doherty; Dora Eugenia Carranza Salazar; JUAN MANUEL CARREÑO QUIROZ; CLAUDIA CARRANZA SALAZAR; ESMERALDA JUAREZ CARVAJAL; LAURA ELENA CARRETO BINAGHI; LUIS RAMIREZ MARTINEZ; GEORGINA PAZ DE LA ROSA; ROSALIA VIGUERAS MORENO; ALEJANDRO ORTIZ STERN; YOLANDA LOPEZ VIDAL; ALEJANDRO E. MACIAS; JESUS MIGUEL TORRES FLORES; OSCAR ROJAS MARTINEZ; JESUS ALEJANDRO SUAREZ MARTINEZ; GUSTAVO PERALTA SANCHEZ; HISAAKI KAWABATA; IRENE GONZALEZ DOMINGUEZ; JOSE LUIS MARTINEZ GUEVARA; Weina Sun; DAVID SARFATI MIZRAHI; ERNESTO SOTO PRIANTE; HECTOR ELIAS CHAGOYA CORTES; CONSTANTINO LOPEZ MACIAS; FELIPA CASTRO PERALTA; Peter Palese; ADOLFO GARCIA SASTRE; Florian Krammer; BERNARDO LOZANO DUBERNARD10-Feb-2022
2019Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trialPreimpresoModjarrad, K; Roberts, C; Mills, K; Castellano, A; Paolino, K; Muthumani, K; Reuschel, E; Robb, M; Racine, T; Oh, M; Lamarre, C; Zaidi, F; Boyer, J; Kudchodkar, S; Jeong, M; Darden, J; Park, Y; Scott, P; Remigio, C; Parikh, A; Wise, M; Patel, A; Duperret, E; Kim, K; Choi, H; White, S; Bagarazzi, M; May, J; Kane, D; Lee, H; Kobinger, G; Michael, N; Weiner, D; Thomas, S; Maslow, J-
2020Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019ArtículoSean Wei Xiang Ong; Wilnard Yeong Tze Tan; Yi-Hao Chan; Siew-Wai Fong; Laurent Renia; Yee-Sin Leo; David Chien Lye; Barnaby Edward Young28-Jul-2020
2020Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)PreimpresoIwen, P; Stiles, K; Pentella, M-
2020Safety management of nasopharyngeal specimen collection from suspected cases of coronavirus disease 2019PreimpresoQian, Y.; Zeng, T.; Wang, H.; Xu, M.; Chen, J.; Hu, N; Chen, D; Liu, Y-
2020Safety of Ibuprofen in Patients With COVID-19ArtículoSodhi Mohit.; Etminan Mahyar.-
2020Safety testing improvised COVID-19 personal protective equipment based on a modified full-face snorkel maskArtículoGreig P.R..; Carvalho C..; El-Boghdadly K..; Ramessur S..-
2020Saliva: potential diagnostic value and transmission of 2019-nCoV.ArtículoXu Ruoshi.; Cui Bomiao.; Duan Xiaobo.; Zhang Ping.; Zhou Xuedong.; Yuan Quan.-
1-Jan-2022Sample Size Calculations for Variant Surveillance in the Presence of Biological and Systematic BiasesPreimpresoShirlee Wohl; Elizabeth Lee; Bethany DiPrete; Justin Lessler3-Jan-2022
2020Sample-Efficient Deep Learning for COVID-19 Diagnosis Based on CT ScansArtículoXuehai He.; Xingyi Yang.; Shanghang Zhang.; Jinyu Zhao.; Yichen Zhang.; Eric Xing.; Pengtao Xie.-
2020SARS Coronavirus Pathogenesis and Therapeutic Treatment Design.ArtículoSheahan Timothy P..; Baric Ralph S..-
2019SARS coronavirus protein nsp1 disrupts localization of nup93 from the nuclear pore complexPreimpresoGomez, G; Abrar, F; Dodhia, M; Gonzalez, F; Nag, A-
2020SARS Cov2 infection in a renal transplanted patients. A case report.ArtículoE Seminari.; M Colaneri.; M Sambo.; I Gallazzi.; Matteo A Di.; R Silvia.; R Bruno.-
2020SARS to novel coronavirus - Old lessons and new lessonsPreimpresoMcCloskey, B; Heymann, D-